29/08/2026
That’s a wrap on the IFHNOS World Congress 2026 in Brisbane.
Looking back on the past few days, I feel incredibly grateful to have been part of a congress that brought together colleagues from around the world to share experiences, challenge ideas and discuss where head and neck cancer care is heading.
So much is changing. We heard about immunotherapy being used earlier in treatment, including before surgery in selected patients; ways of safely reducing treatment intensity in carefully selected cancers; and advances in HPV-related disease, thyroid cancer, sinonasal tumours, oral cancer and precancerous lesions, and skin cancers.
There were also fascinating discussions around minimally invasive and laser surgery, reconstruction and dental rehabilitation.
For me, one of the most important messages was that progress is not simply about treating the cancer. It is also about understanding the individual patient and, wherever possible, preserving speech, swallowing, appearance and quality of life. Increasingly, surgery, radiation, systemic therapy and immunotherapy are being considered together to find the best treatment for each individual.
It has been a privilege to listen to, learn from and exchange ideas with colleagues from so many different countries. I return home with new knowledge, new perspectives
A special thank you to Professor Sandro Porceddu and the entire organising team for an outstanding congress and for bringing the international head and neck community together in Brisbane.
What a few days. Great Congress IFHNOS 2026.